Should ocrelizumab & cladribine be treated the same way as alemtuzumab in terms of risk of COVID-19?

Should ocrelizumab & cladribine be treated the same way as alemtuzumab in terms of risk of COVID-19?

Neurology Academy

31 March 2020
The ABN guidelines are suggesting that most high efficacy DMTs are treated the same. The MS Academy hosted a debate on 31 March 2020 to discuss whether ocrelizumab and cladribine should be treated in the sa…

Related tracks

See all